A
A Niroshan Siriwardena
Researcher at University of Lincoln
Publications - 236
Citations - 4619
A Niroshan Siriwardena is an academic researcher from University of Lincoln. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 29, co-authored 180 publications receiving 3700 citations. Previous affiliations of A Niroshan Siriwardena include University of Nottingham & De Montfort University.
Papers
More filters
Journal ArticleDOI
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis
Daniel Freeman,Daniel Freeman,Bryony Sheaves,Bryony Sheaves,Guy M. Goodwin,Guy M. Goodwin,Ly-Mee Yu,Alecia Nickless,Paul Harrison,Paul Harrison,Richard Emsley,Annemarie I. Luik,Russell G. Foster,Vanashree Wadekar,Chris Hinds,Andrew Gumley,Ray Jones,Stafford L. Lightman,Steve Jones,Richard P. Bentall,Peter Kinderman,Georgina Rowse,Traolach S. Brugha,Mark Blagrove,Alice M. Gregory,Leanne Fleming,Elaine Walklet,Cris Glazebrook,E. Bethan Davies,Chris Hollis,Gillian Haddock,Bev John,Mark Coulson,David Fowler,David Fowler,Katherine Pugh,John Cape,Peter Moseley,Gary Brown,Claire Hughes,Marc Obonsawin,Sian Coker,Edward R. Watkins,Matthias Schwannauer,Kenneth Macmahon,A Niroshan Siriwardena,Colin A. Espie +46 more
TL;DR: There is strong evidence that insomnia is a causal factor in the occurrence of psychotic experiences and other mental health problems, and the treatment of disrupted sleep might require a higher priority in mental health provision.
Journal ArticleDOI
Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review.
TL;DR: Observed improvements in quality of care for chronic diseases in the Quality and Outcomes Framework were modest, and the impact on costs, professional behavior, and patient experience remains uncertain.
Journal ArticleDOI
Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial
Colin A. Espie,Richard Emsley,Simon D. Kyle,Christopher J. Gordon,Christopher L. Drake,A Niroshan Siriwardena,John Cape,Jason C. Ong,Bryony Sheaves,Russell G. Foster,Daniel Freeman,Joan Costa-Font,Antonia Marsden,Annemarie I. Luik +13 more
TL;DR: Use of dCBT is effective in improving functional health, psychological well-being, and sleep-related quality of life in people reporting insomnia symptoms, strengthening existing recommendations of CBT as the treatment of choice for insomnia.
Journal ArticleDOI
Epidemiology and outcomes from out-of-hospital cardiac arrests in England
Claire Hawkes,Scott J. Booth,Chen Ji,Samantha J. Brace-McDonnell,Samantha J. Brace-McDonnell,Andrew Whittington,James Mapstone,Matthew Cooke,Charles D. Deakin,Chris Gale,Rachael T Fothergill,Jerry P. Nolan,Nigel Rees,Jasmeet Soar,A Niroshan Siriwardena,Terry Brown,Gavin D. Perkins,Gavin D. Perkins +17 more
TL;DR: Cardiac arrest is an important cause of death in England and there is scope to improve outcomes, with less than one in ten patients surviving and survival rates highest amongst those who received bystander CPR and public access defibrillation.
Journal ArticleDOI
Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration
Tania B. Huedo-Medina,Irving Kirsch,Irving Kirsch,Jo Middlemass,Markos Klonizakis,A Niroshan Siriwardena +5 more
TL;DR: Compared with placebo, Z drugs produce slight improvements in subjective and polysomnographic sleep latency, especially with larger doses and regardless of type of drug.